Christine Funke, MD
Show Description +
In this roundtable discussion from the Interventional Glaucoma Consortium (IGC) 2024, Christine Funke, MD, discusses the important role of high-volume, high-pressure delivery of viscoelastic during canaloplasty with the iTrack™ Advance (Nova Eye Medical). Specifically, she addresses the ability of the iTrack™ Advance to optimize the delivery of OVD into the canal via the effect of shear thinning. She also reviews data from the International Glaucoma Surgery Registry (IGSR) that examine the impact of OVD volume on clinical outcomes.
Posted: 4/21/2025
Christine Funke, MD
In this roundtable discussion from the Interventional Glaucoma Consortium (IGC) 2024, Christine Funke, MD, discusses the important role of high-volume, high-pressure delivery of viscoelastic during canaloplasty with the iTrack™ Advance (Nova Eye Medical). Specifically, she addresses the ability of the iTrack™ Advance to optimize the delivery of OVD into the canal via the effect of shear thinning. She also reviews data from the International Glaucoma Surgery Registry (IGSR) that examine the impact of OVD volume on clinical outcomes.
Posted: 4/21/2025
Combined Canaloplasty and Cataract Surgery: Considerations for Implementation and Adoption
The Opportunity in Canaloplasty
Restoring the Anatomy with Canaloplasty
Understanding the Mechanisms Associated With Canaloplasty
Case Review: Canaloplasty in a Case of Steroid-Induced Uncontrolled Ocular Hypertension
The Versatility of Standalone Canaloplasty
Targeting and Treating All Glaucoma Anatomy with Canaloplasty
Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 2
Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 1
About Nova Eye Medical
WE ARE NOVA EYE MEDICAL
With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.
Visit Us Online: nova-eye.com
Follow Nova Eye Medical
The Nova Eye iTrack™ Advance is indicated for fluid infusion or aspiration during surgery.
The Nova Eye iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.*
The Nova Eye iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma.
* The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma.